Two Sigma Advisers’s Eledon Pharmaceuticals ELDN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-13,100
| Closed | -$17.9K | – | 2537 |
|
|
2023
Q3 | $17.9K | Sell |
13,100
-9,900
| -43% | -$13.6K | ﹤0.01% | 2327 |
|
|
2023
Q2 | $31.5K | Sell |
23,000
-2,100
| -8% | -$2.88K | ﹤0.01% | 2303 |
|
|
2023
Q1 | $59.2K | Sell |
25,100
-500
| -2% | -$1.18K | ﹤0.01% | 2434 |
|
|
2022
Q4 | $58.4K | Sell |
25,600
-16,600
| -39% | -$37.8K | ﹤0.01% | 2349 |
|
|
2022
Q3 | $116K | Sell |
42,200
-2,800
| -6% | -$7.7K | ﹤0.01% | 2289 |
|
|
2022
Q2 | $110K | Sell |
45,000
-39,011
| -46% | -$95.4K | ﹤0.01% | 2381 |
|
|
2022
Q1 | $331K | Sell |
84,011
-43,589
| -34% | -$172K | ﹤0.01% | 2178 |
|
|
2021
Q4 | $563K | Buy |
127,600
+11,700
| +10% | +$51.6K | ﹤0.01% | 1861 |
|
|
2021
Q3 | $716K | Buy |
115,900
+37,600
| +48% | +$232K | ﹤0.01% | 1771 |
|
|
2021
Q2 | $619K | Buy |
78,300
+60,200
| +333% | +$476K | ﹤0.01% | 1850 |
|
|
2021
Q1 | $194K | Buy |
+18,100
| New | +$194K | ﹤0.01% | 2358 |
|